Neuromuscular stimulator enters US trial:
This article was originally published in Clinica
Executive Summary
NeuroControl has begun a multi-centre clinical trial in the US to assess its minimally invasive neuromuscular stimulator for treating shoulder pain in patients who have suffered a stroke. The StIM system is a miniaturised, multi-channel, programmable device designed to reduce shoulder pain and subluxation - the separation of the shoulder joint due to weak muscles. It delivers therapeutic stimulation through electrodes placed in the shoulder muscles. The Cleveland, Ohio based company CE-marked the StIM device for sale in Europe in January (see Clinica No 892, p 25).